HopeStage
Back to all studies
CompletedNCT01733602

tDCS to Enhance Cognitive Training in Schizophrenia

Device studyAges 18–65Australia
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
SydneySee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study clarity

Study information

Study start dateNovember 2012
Recruitment status
Completed
Enrollment listed in the registry
52
Sponsor
The University of New South Wales
Sponsor type
University
Study type
Device
Intervention type
DEVICE
Study phase
Phase 1, Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Australia
Age range
From 18 Years to 65 Years
Official registry ID
NCT01733602
Official title
Show the full official title

Does Transcranial Direct Current Stimulation (tDCS) Enhance Outcomes From Computerised Cognitive Remediation in Patients With Schizophrenia?

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

Sydney

FAQ

Questions about this study

Who is behind this study?

The study sponsor is The University of New South Wales, a university.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies